Literature DB >> 2774488

Continuous and intermittent levodopa differentially affect basal ganglia function.

J L Juncos1, T M Engber, R Raisman, Z Susel, F Thibaut, A Ploska, Y Agid, T N Chase.   

Abstract

The effects of continuous and intermittent levodopa treatment on behavioral and biochemical indexes of basal ganglia function were compared in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal dopamine pathway. Animals treated for 30 days with intermittent levodopa exhibited behavioral sensitization manifested by an enhanced rotational response to apomorphine; the rotational response of rats treated with an equivalent dose of levodopa by continuous infusion did not differ from that of saline-treated controls. Dopamine receptor up-regulation in the denervated striatum relative to the intact striatum was statistically significant for D1 but not D2 receptors: This asymmetry in dopamine receptor levels was diminished following intermittent levodopa treatment. Glutamic acid decarboxylase activity, modestly elevated in all groups in the denervated striatum relative to the intact striatum, increased substantially over control values bilaterally as a result of intermittent, but not continuous, levodopa treatment. These findings suggest a relation between the schedule of chronic levodopa administration and the development of behavioral sensitization, possibly as a consequence of alterations in neuronal systems located downstream from striatal dopamine receptors. The behavioral sensitization induced by chronic, intermittent dopaminomimetic treatment may serve as a model for motor fluctuations in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2774488     DOI: 10.1002/ana.410250509

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  14 in total

Review 1.  Soluble and controlled-release preparations of levodopa: do we really need them?

Authors:  Giovanni Fabbrini; Flavio Di Stasio; Maria Bloise; Alfredo Berardelli
Journal:  J Neurol       Date:  2010-11       Impact factor: 4.849

Review 2.  Continuous drug delivery in early- and late-stage Parkinson's disease as a strategy for avoiding dyskinesia induction and expression.

Authors:  P Jenner; A C McCreary; D K A Scheller
Journal:  J Neural Transm (Vienna)       Date:  2011-09-01       Impact factor: 3.575

3.  Chronic levodopa impairs the recovery of dopamine agonist-induced rotational behavior following neural grafting.

Authors:  D M Yurek; K Steece-Collier; T J Collier; J R Sladek
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

Review 4.  Parkinson's disease.

Authors:  C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-06       Impact factor: 10.154

5.  Evaluation of the Cytotoxicity of Levodopa and its Complex with Hydroxypropyl-ß-Cyclodextrin (HP-ß-CD) to an Astrocyte Cell Line.

Authors:  Zarif Mohamed Sofian; Shazrin Shazira Shafee; Jafri Malin Abdullah; Hasnah Osman; Shariza Abdul Razak
Journal:  Malays J Med Sci       Date:  2014-12

6.  The effect of dopamine D1 receptor stimulation on the up-regulation of histamine H3-receptors following destruction of the ascending dopaminergic neurones.

Authors:  J H Ryu; K Yanai; X L Zhao; T Watanabe
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

Review 7.  Continuous drug delivery in Parkinson's disease.

Authors:  Marina Senek; Dag Nyholm
Journal:  CNS Drugs       Date:  2014-01       Impact factor: 5.749

8.  High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats.

Authors:  Emilie Lacombe; Carole Carcenac; Sabrina Boulet; Claude Feuerstein; Anne Bertrand; Annie Poupard; Marc Savasta
Journal:  Eur J Neurosci       Date:  2007-09-06       Impact factor: 3.386

9.  L-dopa infusion mode differentially affects corpus striatal dopamine efflux in the presence of reserpine.

Authors:  D E Dluzen; F T Kratko
Journal:  J Neural Transm Gen Sect       Date:  1992

10.  A complex program of striatal gene expression induced by dopaminergic stimulation.

Authors:  J D Berke; R F Paletzki; G J Aronson; S E Hyman; C R Gerfen
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.